UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Increased by Traphagen Investment Advisors LLC

Traphagen Investment Advisors LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 16.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,172 shares of the healthcare conglomerate’s stock after acquiring an additional 167 shares during the quarter. Traphagen Investment Advisors LLC’s holdings in UnitedHealth Group were worth $593,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Delta Financial Group Inc. boosted its holdings in UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares during the last quarter. First PREMIER Bank increased its stake in UnitedHealth Group by 7.0% in the third quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock valued at $160,000 after purchasing an additional 18 shares in the last quarter. Genesee Capital Advisors LLC boosted its position in shares of UnitedHealth Group by 1.9% during the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after purchasing an additional 18 shares in the last quarter. Jmac Enterprises LLC raised its stake in UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after buying an additional 18 shares during the period. Finally, Matrix Private Capital Group LLC grew its stake in UnitedHealth Group by 3.6% in the second quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock valued at $276,000 after acquiring an additional 19 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. Morgan Stanley decreased their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Royal Bank of Canada decreased their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Finally, Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Two research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $524.78 on Wednesday. The stock’s 50 day moving average is $547.07 and its 200-day moving average is $563.84. The company has a market capitalization of $482.95 billion, a price-to-earnings ratio of 33.86, a PEG ratio of 1.38 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the firm earned $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.77 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.